Downregulation of Angiogenin transcript levels and inhibition of colonic carcinoma by Gum Arabic (Acacia senegal)

Nutrition and Cancer

Volumn 62, Issue 6, 2010, Pages 802-810

  Nasir, Omaima ^a   Wang, Kan ^a   Foller, Michael ^a   Bhandaru, Madhuri ^a   Sandulache, Diana ^a   Artunc, Ferruh ^a   Ackermann, Teresa F ^a   Ebrahim, Ammar ^a   Palmada, Monica ^a,b   Klingel, Karin ^a   Saeed, Amal M ^c   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c UNIVERSITY OF KHARTOUM   (Sudan)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIMETHYLHYDRAZINE; AMINO ACID TRANSPORTER; ANGIOGENIN; ANGIOGENIN 1; ANGIOGENIN 3; ANGIOGENIN 4; AQUAPORIN 4; BETA CATENIN; CD38 ANTIGEN; DEXTRAN SULFATE; DRINKING WATER; GUM ARABIC; INTERLEUKIN 18; RANTES; SULFATASE; SULFATASE 1; UBIQUITIN; UBIQUITIN D; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; MESSENGER RNA; PANCREATIC RIBONUCLEASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; COLON CARCINOGENESIS; COLON CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENETIC TRANSCRIPTION; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; ONCOGENE; PROTEIN EXPRESSION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; COLONIC NEOPLASMS; GENETICS;

1,2-DIMETHYLHYDRAZINE; ANIMALS; ANTICARCINOGENIC AGENTS; COLONIC NEOPLASMS; DOWN-REGULATION; FEMALE; GUM ARABIC; MALE; MICE; MICE, INBRED BALB C; RIBONUCLEASE, PANCREATIC; RNA, MESSENGER;

ACACIA SENEGAL; MUS;

EID: 77955001716     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635581003605920     Document Type: Article

References (65)

1. Tiss A, Carriere F, and Verger R: Effects of gum Arabic on lipase interfacial binding and activity. Anal Biochem 294, 36-43, 2001.
2. Younes H, Garleb K, Behr S, Remesy C, and Demigne C: Fermentable fibers or oligosaccharides reduce urinary nitrogen excretion by increasing urea disposal in the rat cecum. J Nutr 125, 1010-1016, 1995.
3. Deckwer RD, Deckwer WD, Dill B, Heiker FR, Kirschning A, et al.: Rompp [online]. Version 2.9. 2006.
4. Verbeken D, Dierckx S, and Dewettinck K: Exudate gums: occurrence, production, and applications. Appl Microbiol Biotechnol 63, 10-21, 2003.
5. Phillips GO: Acacia gum (gum Arabic): a nutritional fibre; metabolism and calorific value. FoodAddit Contam 15, 251-264, 1998.
6. Anderson DM: Evidence for the safety of gum Arabic (Acacia Senegal (L.) Willd.) as a food additive-a brief review. Food Addit Contam 3, 225-230, 1986.
7. Ibrahim MA, Kohn N, and Wapnir RA: Proabsorptive effect of gum Arabic in isotonic solutions orally administered to rats: effect on zinc and other solutes. J Nutr Biochem 15, 185-189, 2004.
8. Teichberg S, Wingertzahn MA, Moyse J, and Wapnir RA: Effect of gum Arabic in an oral rehydration solution on recovery from diarrhea in rats. J Pediatr Gastroenterol Nutr 29, 411-417, 1999.
9. Wapnir RA, Wingertzahn MA, Moyse J, and Teichberg S: Gum Arabic promotes rat jejunal sodium and water absorption from oral rehydration solutions in two models of diarrhea. Gastroenterology 112, 1979-1985, 1997.
10. Al Majed AA, Mostafa AM, Al Rikabi AC, and Al Shabanah OA: Protective effects of oral Arabic gum administration on gentamicin-induced nephrotoxicity in rats. Pharmacol Res 46, 445-451, 2002.
11. Bliss DZ: Dietary fiber in conservative management of chronic renal failure. Pediatr Nephrol 19, 1069-1070, 2004.
12. Stephen AM and Cummings JH: The microbial contribution to human faecal mass. J Med Microbiol 13, 45-56, 1980.
13. Ali BH, Al Qarawi AA, Haroun EM, and Mousa HM: The effect of treatment with gum Arabic on gentamicin nephrotoxicity in rats: a preliminary study. Ren Fail 25, 15-20, 2003.
14. Fett JW, Strydom DJ, Lobb RR, Alderman EM, Bethune JL, et al.: Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 24, 5480-5486, 1985.
15. Yoshioka N, Wang L, Kishimoto K, Tsuji T, and Hu GF: A therapeutic target for prostate cancer based on angiogenin-stimulated angiogenesis and cancer cell proliferation. Proc Natl Acad Sci USA 103, 14519-14524, 2006.
16. Li D, Bell J, Brown A, and Berry CL: The observation of angiogenin and basic fibroblast growth factor gene expression in human colonic adenocarcinomas: gastric adenocarcinomas, and hepatocellular carcinomas. J Pathol 172, 171-175, 1994.
17. Shimoyama S, Shimizu N, Tsuji E, Yamasaki K, Kawahara M, et al.: Distribution of angiogenin and its gene message in colorectal cancer patients and their clinical relevance. Anticancer Res 22, 1045-1052, 2002.
18. Shimoyama S and Kaminishi M: Increased angiogenin expression in gastric cancer correlated with cancer progression. J Cancer Res Clin Oncol 126, 468-474, 2000.
19. Hisai H, Kato J, Kobune M, Murakami T, Miyanishi K, et al.: Increased expression of angiogenin in hepatocellular carcinoma in correlation with tumor vascularity. Clin Cancer Res 9, 4852-4859, 2003.
20. Shimoyama S, Gansauge F, Gansauge S, Negri G, Oohara T, et al.: Increased angiogenin expression in pancreatic cancer is related to cancer aggressiveness. Cancer Res 56, 2703-2706, 1996.
21. Chopra V, DinhTV, andHanniganEV: Serum levels ofinterleukins, growth factors and angiogenin in patients with endometrial cancer. J Cancer Res Clin Oncol 123, 167-172, 1997.
22. Chopra V, Dinh TV, and Hannigan EV: Circulating serum levels of cy- tokines and angiogenic factors in patients with cervical cancer. Cancer Invest 16, 152-159, 1998.
23. Montero S, Guzman C, Cortes-Funes H, and Colomer R: Angiogenin expression and prognosis in primary breast carcinoma. Clin Cancer Res 4, 2161-2168, 1998.
24. Barton DP, Cai A, Wendt K, Young M, Gamero A, et al.: Angiogenic protein expression in advanced epithelial ovarian cancer. Clin Cancer Res 3, 1579-1586, 1997.
25. Katona TM, Neubauer BL, Iversen PW, Zhang S, Baldridge LA, et al.: Elevated expression of angiogenin in prostate cancer and its precursors. Clin Cancer Res 11, 8358-8363, 2005.
26. Majumder PK, Febbo PG, Bikoff R, Berger R, Xue Q, et al.: MTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways. Nat Med 10, 594-601, 2004.
27. Miyake H, Hara I, Yamanaka K, Gohji K, Arakawa S, et al.: Increased angiogenin expression in the tumor tissue and serum of urothelial carcinoma patients is related to disease progression and recurrence. Cancer 86, 316-324, 1999.
28. Wechsel HW, Bichler KH, Feil G, Loeser W, LahmeS, et al.: Renal cell carcinoma: relevance of angiogenetic factors. Anticancer Res 19, 1537-1540, 1999. (Pubitemid 29255642)
29. Eberle K, Oberpichler A, Trantakis C, Krupp W, Knupfer M, et al.: The expression of angiogenin in tissue samples of different brain tumours and cultured glioma cells. Anticancer Res 20, 1679-1684, 2000.
30. Kushlinskii NE, Babkina IV, Solov'ev YN, and Trapeznikov NN: Vascular endothelium growth factor and angiogenin in the serum of patients with osteosarcoma and Ewing's tumor. Bull Exp Biol Med 130, 691-693, 2000.
31. Brunner B, Gunsilius E, Schumacher P, Zwierzina H, Gastl G, et al.: Blood levels of angiogenin and vascular endothelial growth factor are elevated in myelodysplastic syndromes and in acute myeloid leukemia. J Hematother Stem Cell Res 11, 119-125, 2002.
32. Verstovsek S, Kantarjian H, Aguayo A, Manshouri T, Freireich E, et al.: Significance of angiogenin plasma concentrations in patients with acute myeloid leukaemia and advanced myelodysplastic syndrome. Br J Haematol 114, 290-295, 2001. (Pubitemid 32762226)
33. Bertolini F, Paolucci M, Peccatori F, Cinieri S, Agazzi A, et al.: Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma. Br J Haematol 106, 504-509, 1999.
34. Hartmann A, Kunz M, Kostlin S, Gillitzer R, Toksoy A, et al.: Hypoxia- induced up-regulation of angiogenin in human malignant melanoma. Cancer Res 59, 1578-1583, 1999.
35. Skoldenberg EG, Christiansson J, Sandstedt B, Larsson A, Lackgren G, et al.: Angiogenesis and angiogenic growth factors in Wilms tumor. J Urol 165, 2274-2279, 2001.
36. Nasir O, Artunc F, Saeed A, Kambal MA, Kalbacher H, et al.: Effects of Gum Arabic (Acacia Senegal) on water and electrolyte balance in healthy mice. J Ren Nutr 18, 230-238, 2008.
37. Nasir O, Wang K, Foller M, Gu S, Bhandaru M, et al.: Relative resistance of SGK1 knockout mice against chemical carcinogenesis. IUBMB Life 61, 768-776, 2009.
38. Wang JG, Wang DF, Lv BJ, and Si JM: A novel mouse model for colitis- associated colon carcinogenesis induced by 1,2-dimethylhydrazine and dex- tran sulfate sodium. World J Gastroenterol 10, 2958-2962, 2004.
39. Cummings JH, Bingham SA, Heaton KW, and Eastwood MA: Fecal weight, colon cancer risk, and dietary intake of nonstarch polysaccharides (dietary fiber). Gastroenterology 103, 1783-1789, 1992.
40. Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Stampfer MJ et al.: Dietary fiber and the risk of colorectal cancer and adenoma in women. N Engl J Med 340, 169-176, 1999.
41. Abdel-Rahman AM, el Sahrigy SA, and Bakr SI: A comparative study of two angiogenic factors: vascular endothelial growth factor and angiogenin in induced sputum from asthmatic children in acute attack. Chest 129, 266-271, 2006.
42. Hooper LV, StappenbeckTS, Hong CV, and Gordon JI: Angiogenins: anew class of microbicidal proteins involved in innate immunity. Nat Immunol 4, 269-273, 2003.
43. Hoshino M, Takahashi M, and Aoike N: Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol 107, 295-301, 2001.
44. Liote F, Champy R, Moenner M, Boval-Boizard B, and Badet J: Elevated angiogenin levels in synovial fluid from patients with inflammatory arthritis and secretion of angiogenin by cultured synovial fibroblasts. Clin Exp Immunol 132, 163-168, 2003.
45. Maruotti N, Cantatore FP, Crivellato E, Vacca A, and Ribatti D: Angiogenesis in rheumatoid arthritis. Histol Histopathol 21, 557-566, 2006.
46. Olson KA, Verselis SJ, and Fett JW: Angiogenin is regulated in vivo as an acute phase protein. Biochem Biophys Res Commun 242, 480-483, 1998.
47. Suzumori N, Zhao XX, and Suzumori K: Elevated angiogenin levels in the peritoneal fluid of women with endometriosis correlate with the extent of the disorder. Fertil Steril 82, 93-96, 2004.
48. Koutroubakis IE, Xidakis C, Karmiris K, Sfiridaki A, Kandidaki E, et al.: Serum angiogenin in inflammatory bowel disease. Dig Dis Sci 49, 1758-1762, 2004.
49. Finley JW, Burrell JB, and Reeves PG: Pinto bean consumption changes SCFA profiles in fecal fermentations, bacterial populations of the lower bowel, and lipid profiles in blood of humans. JNutr 137, 2391-2398, 2007.
50. Ishikawa S, Asano T, Takenoshita S, Nozawa Y, Arihara K, et al.: Egg yolk proteins suppress azoxymethane-induced aberrant crypt foci formation and cell proliferation in the colon of rats. Nutr Res 29, 64-69, 2009.
51. Pool-Zobel BL: Inulin-type fructans and reduction in colon cancer risk: review of experimental and human data. Br J Nutr 93(1 Suppl.), S73-S90, 2005.
52. Usami M, Kishimoto K, Ohata A, Miyoshi M, Aoyama M, et al.: Bu- tyrate and trichostatin A attenuate nuclear factor kappaB activation and tumor necrosis factor alpha secretion and increase prostaglandin E2 secretion in human peripheral blood mononuclear cells. Nutr Res 28, 321-328, 2008.
53. Basson MD, Emenaker NJ, and Hong F: Differential modulation of human (caco-2) colon cancer cell line phenotype by short-chain fatty acids. Proc Soc Exp Biol Med 217, 476-483, 1998.
54. Campbell CT, Aich U, Weier CA, Wang JJ, Choi SS, et al.: Targeting pro-invasive oncogenes with short-chain fatty acid-hexosamine analogues inhibits the mobility of metastatic MDA-MB-231 breast cancer cells. JMed Chem 51, 8135-8147, 2008.
55. Chen JS, Faller DV, and Spanjaard RA: Short-chain fatty acid inhibitors of histone deacetylases: promising anticancer therapeutics? Curr Cancer Drug Targets 3, 219-236, 2003.
56. Deaglio S, Aydin S, Vaisitti T, Bergui L, and Malavasi F: CD38 at the junction between prognostic marker and therapeutic target. Trends Mol Med 14, 210-218, 2008.
57. Dinarello CA: The paradox of pro-inflammatory cytokines in cancer. Cancer Metastasis Rev 25, 307-313, 2006.
58. Katzav S: Vav: captain hook for signal transduction? Crit Rev Oncog 6, 87-97, 1995.
59. Kanai Y and Endou H: Heterodimeric amino acid transporters: molecular biology and pathological and pharmacological relevance. CurrDrug Metab 2, 339-354, 2001.
60. Aka JA, Mazumdar M, and Lin SX: Reductive 17beta-hydroxysteroid de- hydrogenases in the sulfatase pathway: critical in the cell proliferation of breast cancer. Mol Cell Endocrinol 301, 183-190, 2009.
61. Lai JP, Thompson JR, Sandhu DS, and Roberts LR: Heparin-degrading sulfatases in hepatocellular carcinoma: roles in pathogenesis and therapy targets. Future Oncol 4, 803-814, 2008.
62. Orlowski RZ and Kuhn DJ: Proteasome inhibitors in cancer therapy: lessons from the first decade. Clin Cancer Res 14, 1649-1657, 2008.
63. Sancho-Martinez I and Martin-Villalba A: Tyrosine phosphorylation and CD95: a FAScinating switch. Cell Cycle 8, 838-842, 2009.
64. Jin T, George FI, and Sun J: Wnt and beyond wnt: Multiple mechanisms control the transcriptional property of beta-catenin. Cell Signal 20, 1697-1704, 2008.
65. Kim YS and Milner JA: Dietary modulation of colon cancer risk. J Nutr 137, 2576S-2579S, 2007.